0.9476
0.0076 (0.81%)
0.0076 (0.81%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aeterna Zentaris Inc | AEZS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.0076 | 0.81% | 0.9476 | 00:00:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.95 | 0.777 | 0.96 | 0.92 | 0.94 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.93 | 1.28 | 0.35 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 13,371 | 9,249,290 | $ 0.8717562 | $ 8,063,126 | 6,851,343 | 0.29 - 3.62 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:50 | formt | 1,500 | $ 0.9476 | USD |
Aeterna Zentaris Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 59.39M | 62.68M | 16.44M | $ 543.03k | $ - | 0.25 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Aeterna Zentaris News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AEZS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.10 | 1.25 | 0.777 | 1.08 | 7,476,861 | -0.1524 | -13.85% |
| 1 Month | 1.09 | 3.62 | 0.777 | 2.33 | 28,172,814 | -0.1424 | -13.06% |
| 3 Months | 0.38 | 3.62 | 0.3594 | 1.60 | 17,589,502 | 0.5676 | 149.37% |
| 6 Months | 0.3799 | 3.62 | 0.29 | 1.44 | 9,211,407 | 0.5677 | 149.43% |
| 1 Year | 0.785 | 3.62 | 0.29 | 1.24 | 5,778,669 | 0.1626 | 20.71% |
| 3 Years | 1.78 | 5.5869 | 0.29 | 1.33 | 2,116,445 | -0.8324 | -46.76% |
| 5 Years | 3.65 | 5.59 | 0.29 | 1.54 | 1,540,998 | -2.70 | -74.04% |
Aeterna Zentaris Description
| AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company is actively pursuing opportunities to commercialize macimorelin in the EU & the rest of the world. |
